Choy F Y, Humphries M L, Shi H
Centre for Environmental Health, Department of Biology, University of Victoria, B.C., Canada.
Am J Med Genet. 1997 Aug 8;71(2):172-8. doi: 10.1002/(sici)1096-8628(19970808)71:2<172::aid-ajmg10>3.0.co;2-b.
Gaucher disease is the most prevalent lysosomal storage disease. It is panethnic and results from an inherited deficiency of glucocerebrosidase. Most mutations to date have been identified among Jewish and non-Jewish Caucasian patients; mutations in Chinese patients are largely unknown. We have performed nucleotide sequence analysis of PCR-amplified glucocerebrosidase genomic DNA from five unrelated Chinese patients affected with type 1 (non-neuropathic) Gaucher disease. A novel heterozygous C --> T mutation at cDNA nucleotide position 475 (R120W) was detected in a patient who is also heterozygous for a C --> T transition at cDNA nucleotide position 259 (R48W). In a second patient, a novel, heterozygous T --> G transversion at cDNA 226 (F37V) was detected. Mutation 1448 (L444P), the most prevalent mutation among non-Jewish Caucasian Gaucher patients, was found in the heterozygous form in four patients. The mutations in the second Gaucher allele in the other three patients are mutations 254 (G46E), 680 (N188S), and 754 (F213I), which were recently reported in Korean, Arab, and Chinese (Taiwanese) patients. We have developed screening methods that utilize PCR amplification of glucocerebrosidase genomic DNA and Eco571, Nci1, Hinc11, BsaJ1, and Bsr1 restriction endonuclease analyses for the detection of each of these mutations. The population genetics of some of these Gaucher alleles and their implications in genotype/phenotype correlation are discussed.
戈谢病是最常见的溶酶体贮积病。它具有全种族性,由葡糖脑苷脂酶的遗传性缺乏所致。迄今为止,大多数突变是在犹太和非犹太白种人患者中发现的;中国患者中的突变情况大多未知。我们对5名患有1型(非神经病变型)戈谢病的无关中国患者的葡糖脑苷脂酶基因组DNA进行了PCR扩增后的核苷酸序列分析。在一名患者中检测到cDNA核苷酸位置475处有一个新的杂合C→T突变(R120W),该患者在cDNA核苷酸位置259处(R48W)也是C→T转换的杂合子。在第二名患者中,检测到cDNA 226处有一个新的杂合T→G颠换(F37V)。非犹太白种人戈谢病患者中最常见的突变1448(L444P)在4名患者中以杂合形式被发现。其他3名患者的第二个戈谢病等位基因中的突变分别是254(G46E)、680(N188S)和754(F213I),这些突变最近在韩国、阿拉伯和中国(台湾)患者中被报道。我们开发了利用葡糖脑苷脂酶基因组DNA的PCR扩增以及Eco571、Nci1、Hinc11、BsaJ1和Bsr1限制性内切酶分析来检测这些突变的筛查方法。讨论了其中一些戈谢病等位基因的群体遗传学及其在基因型/表型相关性中的意义。